Pet Oral Care Products Market Size, Growth & Forecast 2026-2031

Executive Overview: A Market Anchored in Clinical Need and Humanization

The global pet oral care products market is estimated at USD 3.24 billion in 2026 and is forecast to reach USD 4.43 billion by 2031, expanding at a 6.46% CAGR. This trajectory is underpinned by an unyielding clinical reality: periodontal disease affects more than 8 in 10 adult companion animals, making oral care the single largest preventable health burden in veterinary practice.

• Base year (2026) market value: USD 3.24 billion
• Forecast year (2031) market value: USD 4.43 billion
• CAGR (2026–2031): 6.46%
• Fastest-growing region: Asia-Pacific
• Largest regional market: North America (46.5% revenue share in 2025)

Our proprietary demand modeling indicates that preventive product adoption is no longer a discretionary premium niche. It is transitioning into a recurring, protocol-driven purchase behavior, reinforced by e-commerce subscriptions and veterinarian-recommended regimens.

Market Drivers and Restraints: A High-Compliance Growth Path

The market’s growth engine is fueled by six quantifiable forces, each with a distinct impact on the forecast CAGR. Our primary interviews with veterinary professionals and brand managers confirm that the following drivers are additive rather than substitutive.

Key restraints include low owner compliance with tooth-brushing regimens (estimated −0.8% impact on CAGR), inflation-driven price sensitivity in emerging markets, counterfeit risk in online channels, and variable claim regulations across jurisdictions.

Product and Animal Segmentation: Chews Dominate, Probiotics Accelerate

By product type, dental chews and treats led with 41.3% of the market share in 2025, while oral probiotic tablets are forecast to expand at a 7.4% CAGR through 2031. This reflects a structural shift toward products that reduce owner effort without compromising clinical efficacy.

• Toothpaste: Enzymatic, non-enzymatic, and flavored variants remain the clinical foundation.
• Toothbrushes: Finger brushes, standard dog brushes, cat toothbrushes, and electric models.
• Mouthwash and rinses: Water additives and breath-freshening solutions.
• Dental chews and treats: Rawhide, grain-free, enzymatic, dental bones, and star-shaped chews.
• Oral probiotic tablets and powders: Postbiotic and microbiome-targeted formulations.
• Other: Gels, sealants, wipes, sprays, and complete dental kits.

By animal type, dogs accounted for a 64.5% share of market size in 2025, and cats are advancing at a 6.1% CAGR to 2031. Smaller breeds (Beagles, Chihuahuas, Dachshunds) show disproportionately high periodontal disease rates, creating demand for breed-specific and size-specific chews.

Distribution Channel Dynamics: Online and Subscriptions Reshape Access

Online platforms captured 36.7% of revenue share in 2025, and subscription boxes are projected to grow at a 7.9% CAGR through 2031. The channel mix is rapidly evolving as consumers prioritize convenience, auto-reorder functionality, and same-day delivery.

Veterinary clinics remain the primary source of professional recommendation and seal-of-acceptance validation (e.g., VOHC). However, the final purchase is increasingly shifting online, requiring brands to integrate veterinary endorsement with DTC fulfillment.

Regional Outlook: North America Leads, Asia-Pacific Accelerates

North America held a 46.5% share in 2025, supported by high pet humanization, advanced veterinary infrastructure, and strong e-commerce penetration. Europe follows with a mature but innovation-driven market, where regulatory clarity on functional claims is shaping formulation strategies.

Asia-Pacific is the fastest-growing region, with a 6.6% CAGR to 2031. Urbanization, rising pet ownership in China and Japan, and expanding online retail are the primary catalysts. However, price sensitivity and counterfeit risk require localized authentication and pack-size strategies.

• North America: Focus on premiumization, microbiome science, and subscription models.
• Europe: Emphasis on natural ingredients, clinical validation, and sustainability.
• Asia-Pacific: Volume growth through e-commerce and mid-tier pricing.
• South America: Humanization trend offset by taxation and disposable income constraints (e.g., Brazil).
• Middle East & Africa: Emerging demand, largely import-dependent.

Competitive Landscape and Strategic Developments

The market is moderately concentrated, with the leading players collectively accounting for a significant revenue share. Our primary research identifies the following companies as key participants:

Mars, Incorporated; Colgate-Palmolive Company; Nestlé Purina PetCare; Virbac S.A.; Elanco Animal Health Incorporated; Vetoquinol S.A.; Central Garden & Pet Company; Hill's Pet Nutrition; Blue Buffalo Co. Ltd.; TropiClean; HealthyMouth LLC; PetzLife Products Inc.; Kane Biotech; Natural Pet Innovations; Nylabone; Whimzees; Petosan AS; Petsmile; Arm & Hammer Pet Dental; Vet's Best; ProDen PlaqueOff; OraVet; Goran Pharma; Cosmos Corporation; Beaphar Beheer BV; Sentry Pet Care; Ark Naturals Company.

Recent developments:

• September 2024: Vimian Group AB acquired iM3 Dental Limited, strengthening veterinary dental equipment capabilities.
• January 2025: Saint Roch Veterinary launched GingiGuard, a non-systemic topical treatment restoring oral microbiome balance for over four weeks.
• January 2023: TEEF for Life introduced SMMRT and Protektin42, pre- and postbiotic powder targeting gum disease and bad breath in canines.
• Ongoing: Mars Pet Nutrition deployed AI-powered dental assessment (GREENIES Canine Dental Check) and microbiome-based formulations.

Value Chain and Supply Dynamics

The value chain spans ingredient suppliers (seaweed extract, enzymes, postbiotics), contract manufacturers, brand owners, veterinary distributors, and retail/e-commerce channels. Key input costs include Ascophyllum nodosum harvests, probiotic strain fermentation, and packaging materials.

• Ingredient innovation: Seaweed extract (Ascophyllum nodosum) and postbiotic Lactobacillus plantarum strains demonstrate plaque and halitosis reduction in peer-reviewed trials.
• Manufacturing: Postbiotics offer shelf stability without cold-chain logistics, enabling broader online distribution.
• Procurement risk: Counterfeit products in online marketplaces require authentication technologies (QR codes, blockchain).
• Regulatory variance: Claim regulations differ by country, demanding localized clinical dossiers.

Our supply-side interviews indicate that manufacturers are diversifying ingredient sourcing to mitigate harvest variability and fermentation capacity constraints.

Strategic White-Space and Investment Opportunities

Three white-space areas stand out for investors and incumbents:

• Microbiome-targeted formulations: Species-specific strains for dogs and cats, with early adopters willing to pay premium prices.
• Subscription-first brands: Leveraging auto-reorder to convert compliance gaps into recurring revenue.
• AI-enabled diagnostics integration: Chew design and owner engagement tools that link product usage to digital health monitoring.

Investment attractiveness is highest in Asia-Pacific for volume growth and in North America/Europe for premium innovation. The Ansoff matrix suggests market penetration (existing products, existing markets) remains the dominant strategy, but product development (novel ingredients, personalized formulations) offers the highest margin expansion.

Import/Export and Supplier Dynamics

Trade data indicates that the United States and Germany are net exporters of pet oral care products, while China is a major exporter of dental chews and treats. However, rising tariffs and logistics costs are prompting regionalization of production.

• Key exporting countries: USA, Germany, China, Netherlands.
• Key importing regions: Asia-Pacific (excluding China), Middle East, South America.
• Supply chain risk: Single-source dependency on seaweed extract from specific coastal regions and probiotic fermentation capacity.

Brands are increasingly pursuing dual-sourcing strategies and local manufacturing in target markets to reduce lead times and tariff exposure.